169 related articles for article (PubMed ID: 19879869)
1. Methanandamide blocks amphetamine-induced behavioral sensitization in rats.
Rasmussen BA; Unterwald EM; Kim JK; Rawls SM
Eur J Pharmacol; 2010 Feb; 627(1-3):150-5. PubMed ID: 19879869
[TBL] [Abstract][Full Text] [Related]
2. Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats.
Rasmussen B; Unterwald EM; Rawls SM
Drug Alcohol Depend; 2011 Nov; 118(2-3):484-8. PubMed ID: 21524862
[TBL] [Abstract][Full Text] [Related]
3. Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats.
Meng ZH; Feldpaush DL; Merchant KM
Brain Res Mol Brain Res; 1998 Oct; 61(1-2):39-50. PubMed ID: 9795122
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
Dietz DM; Tapocik J; Gaval-Cruz M; Kabbaj M
Physiol Behav; 2005 Oct; 86(3):347-55. PubMed ID: 16126238
[TBL] [Abstract][Full Text] [Related]
5. Early ontogeny of D-amphetamine-induced one-trial behavioral sensitization.
McDougall SA; Nuqui CM; Quiroz AT; Martinez CM
Pharmacol Biochem Behav; 2013 Mar; 104():154-62. PubMed ID: 23360956
[TBL] [Abstract][Full Text] [Related]
6. Effects of serotonergic manipulations on the behavioral sensitization and disinhibition associated with repeated amphetamine treatment.
Olausson P; Engel JA; Söderpalm B
Pharmacol Biochem Behav; 2000 May; 66(1):211-20. PubMed ID: 10837863
[TBL] [Abstract][Full Text] [Related]
7. Time acts as a conditioned stimulus to control behavioral sensitization to amphetamine in rats.
Arvanitogiannis A; Sullivan J; Amir S
Neuroscience; 2000; 101(1):1-3. PubMed ID: 11068130
[TBL] [Abstract][Full Text] [Related]
8. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine.
Panayi F; Dorso E; Lambás-Señas L; Renaud B; Scarna H; Bérod A
Neuropsychopharmacology; 2002 Jan; 26(1):64-74. PubMed ID: 11751033
[TBL] [Abstract][Full Text] [Related]
9. The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2'4'-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats.
Kittner H; Krügel U; Illes P
Neuroscience; 2001; 102(2):241-3. PubMed ID: 11166110
[TBL] [Abstract][Full Text] [Related]
10. Clozapine pre-treatment has a protracted hypolocomotor effect on the induction and expression of amphetamine sensitization.
Herrera AS; Casanova JP; Gatica RI; Escobar F; Fuentealba JA
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():1-6. PubMed ID: 23954739
[TBL] [Abstract][Full Text] [Related]
11. Stressor- or drug-induced sensitization of the corticosterone response is not critically involved in the long-term expression of behavioural sensitization to amphetamine.
Schmidt ED; Tilders FJ; Binnekade R; Schoffelmeer AN; De Vries TJ
Neuroscience; 1999; 92(1):343-52. PubMed ID: 10392855
[TBL] [Abstract][Full Text] [Related]
12. Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593.
Fuentealba JA; Gysling K; Andrés ME
Synapse; 2007 Sep; 61(9):771-7. PubMed ID: 17568430
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine.
Cador M; Bjijou Y; Stinus L
Neuroscience; 1995 Mar; 65(2):385-95. PubMed ID: 7777156
[TBL] [Abstract][Full Text] [Related]
14. D(3) dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine.
Chiang YC; Chen PC; Chen JC
Brain Res; 2003 May; 972(1-2):159-67. PubMed ID: 12711089
[TBL] [Abstract][Full Text] [Related]
15. The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder.
Valvassori SS; Mariot E; Varela RB; Bavaresco DV; Dal-Pont GC; Ferreira CL; Andersen ML; Tye SJ; Quevedo J
J Affect Disord; 2019 Feb; 245():1106-1113. PubMed ID: 30699853
[TBL] [Abstract][Full Text] [Related]
16. A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats.
Vanderschuren LJ; Schmidt ED; De Vries TJ; Van Moorsel CA; Tilders FJ; Schoffelmeer AN
J Neurosci; 1999 Nov; 19(21):9579-86. PubMed ID: 10531460
[TBL] [Abstract][Full Text] [Related]
17. The laterodorsal tegmentum contributes to behavioral sensitization to amphetamine.
Nelson CL; Wetter JB; Milovanovic M; Wolf ME
Neuroscience; 2007 Apr; 146(1):41-9. PubMed ID: 17321058
[TBL] [Abstract][Full Text] [Related]
18. Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide.
Landa L; Jurajda M; Sulcova A
Neuro Endocrinol Lett; 2012; 33(4):446-52. PubMed ID: 22936253
[TBL] [Abstract][Full Text] [Related]
19. Ibotenic acid lesions of prefrontal cortex do not prevent expression of behavioral sensitization to amphetamine.
Li Y; Wolf ME
Behav Brain Res; 1997 Mar; 84(1-2):285-9. PubMed ID: 9079793
[TBL] [Abstract][Full Text] [Related]
20. Stress during adolescence alters behavioral sensitization to amphetamine.
Kabbaj M; Isgor C; Watson SJ; Akil H
Neuroscience; 2002; 113(2):395-400. PubMed ID: 12127096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
